CareDx, Inc
CDNA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 15.4% | 2.4% | -2.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 68.7% | 66.9% | 66.4% | 67.5% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 6.8% | -6.6% | -3.6% | -17.6% |
| Net Income | $0 | -$0 | -$0 | $0 |
| % Margin | 1.7% | -9.9% | -12.2% | 90.1% |
| EPS Diluted | 0.03 | -0.16 | -0.19 | 1.51 |
| % Growth | 118.8% | 15.8% | -112.6% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |